Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Keller

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Reproductive Biomedicine Online|March 30, 2025
Sociodemographic profile of women seeking elective egg freezing when financed by the public healthcare systemMariam Chehimi, Angèle Boursier, Valérie Lefebvre-Khalil, et al.
Frontiers in Endocrinology|January 9, 2023
Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot studyVirginie Simon, Geoffroy Robin, Laura Keller, et al.
Oncotarget|April 27, 2017
Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinomaNicolas Guibert, Julien Mazieres, Myriam Delaunay, et al.
Reproductive Biology and Endocrinology : RB&E|December 5, 2024
Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?Margaux Lorillon, Geoffroy Robin, Laura Keller, et al.
Cancer Research|November 24, 2021
Current and Future Clinical Applications of ctDNA in Immuno-OncologyJulia-Christina Stadler, Yassine Belloum, Benjamin Deitert, et al.
International Journal of Cancer|January 17, 2022
Is ovarian recovery after chemotherapy in young patients with early breast cancer influenced by controlled ovarian hyperstimulation for fertility preservation or tumor characteristics? Results of a prospective study in 126 patientsAudrey Mailliez, Pascal Pigny, Emilie Bogart, et al.
Cells|November 19, 2020
Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!Lucile Durin, Anne Pradines, Céline Basset, et al.
Reproductive Biology and Endocrinology : RB&E|January 6, 2022
Polycystic ovary syndrome phenotype does not have impact on oocyte morphologyAudrey Uk, Christine Decanter, Camille Grysole, et al.
Reproductive Biomedicine Online|March 7, 2018
Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controlsChristine Decanter, Geoffroy Robin, Audrey Mailliez, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|September 19, 2025
[Fertility preservation for trans men: Barriers and motivations]Héloise Turck, Laura Keller, François Medjkane, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Reproductive Biomedicine Online|March 30, 2025
Sociodemographic profile of women seeking elective egg freezing when financed by the public healthcare systemMariam Chehimi, Angèle Boursier, Valérie Lefebvre-Khalil, et al.
Frontiers in Endocrinology|January 9, 2023
Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot studyVirginie Simon, Geoffroy Robin, Laura Keller, et al.
Oncotarget|April 27, 2017
Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinomaNicolas Guibert, Julien Mazieres, Myriam Delaunay, et al.
Reproductive Biology and Endocrinology : RB&E|December 5, 2024
Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?Margaux Lorillon, Geoffroy Robin, Laura Keller, et al.
Cancer Research|November 24, 2021
Current and Future Clinical Applications of ctDNA in Immuno-OncologyJulia-Christina Stadler, Yassine Belloum, Benjamin Deitert, et al.
International Journal of Cancer|January 17, 2022
Is ovarian recovery after chemotherapy in young patients with early breast cancer influenced by controlled ovarian hyperstimulation for fertility preservation or tumor characteristics? Results of a prospective study in 126 patientsAudrey Mailliez, Pascal Pigny, Emilie Bogart, et al.
Cells|November 19, 2020
Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!Lucile Durin, Anne Pradines, Céline Basset, et al.
Reproductive Biology and Endocrinology : RB&E|January 6, 2022
Polycystic ovary syndrome phenotype does not have impact on oocyte morphologyAudrey Uk, Christine Decanter, Camille Grysole, et al.
Reproductive Biomedicine Online|March 7, 2018
Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controlsChristine Decanter, Geoffroy Robin, Audrey Mailliez, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|September 19, 2025
[Fertility preservation for trans men: Barriers and motivations]Héloise Turck, Laura Keller, François Medjkane, et al.
Pageof 6